Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Inhaled Nitric Oxide in the Treatment of Moderate Persistent Pulmonary Hypertension of the Newborn: A Randomized Controlled, Multicenter Trial

Abstract

OBJECTIVE: Inhaled nitric oxide (iNO) improves oxygenation and reduces the need for extracorporeal membrane oxygenation in infants with severe persistent pulmonary hypertension of the newborn (PPHN). The effectiveness of iNO in the treatment of moderate PPHN has not been adequately defined. We therefore conducted a randomized, prospective multicenter study to assess whether iNO in patients with moderate PPHN would improve arterial paO2, prevent progression to severe PPHN, and improve outcomes.

METHODS: Infants ≥34 weeks gestation with moderate pulmonary hypertension (alveolar–arterial oxygen gradient (AaDO2) 500–599 Torr) were randomly assigned to continue standard medical therapy (control group) or standard medical therapy plus iNO (iNO group). For each patient in the iNO group, iNO concentration was increased in steps of 10–20 ppm every 30 minutes until there was no further improvement in arterial paO2. This concentration of iNO was then maintained while all other ventilatory support, including inspired oxygen concentration, was weaned according to a predefined protocol.

RESULTS: In all, 27 of 40 control patients (58%) compared to six of 40 infants (15%) in the iNO group failed assigned therapy and developed severe PPHN (p<0.0005). Arterial paO2 improved from 112±48 to 133±100 (p=0.132) in control infants compared to an increase from 101±29 to 208±118 (p<0.0005) in iNO-treated patients. For the first 36 hours after study, entry AaDO2 levels and ventilatory support were significantly lower in iNO-treated infants compared to control patients.

CONCLUSION: In patients with moderate PPHN, treatment with iNO improves arterial paO2, reduces the amount of ventilatory support needed, and prevents progression to severe PPHN.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH . Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled Nitric Oxide. J Pediatrics 1993;123(1):103–108.

    Article  CAS  Google Scholar 

  2. Kinsella JP, Truog WE, Walsh WF, et al. Randomized, multicenter trial of inhaled Nitric Oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatrics 1997;131:55–62.

    Article  CAS  Google Scholar 

  3. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled Nitric Oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Medi 1997;336(9):597–604.

  4. Clark HR, Kueser TJ, Walker MW, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med 2000;342(7):469–474.

    Article  CAS  Google Scholar 

  5. Christou H, Van Marter LJ, Wessel DL, et al. Inhaled Nitric Oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn. Crit Care Med 2000;28(11):3722–3727.

    Article  CAS  Google Scholar 

  6. Hintz SR, Suttner DM, Sheehan AM, Rhine WD, Van Meurs KP . Decreased use of neonatal extracorporeal membrane oxygenation (ECMO): how new treatment modalities have affected ECMO utilization. Pediatrics 2000;106(6):1339–1343.

    Article  CAS  Google Scholar 

  7. Walsh-Sukys M, Tyson J, Wright L, et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 2000;105(1):14–20.

    Article  CAS  Google Scholar 

  8. Davidson D, Barefield ES, Kattwinkel J, et al. Inhaled Nitric Oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose–response, multicenter study. Pediatrics 1998;101(3):325–334.

    Article  CAS  Google Scholar 

  9. The Franco-Belgium NO Trial Group. Early compared with delayed iNO in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial. Lancet 1999;354:1066–1071.

  10. Clark HR, Yoder B, Sell MS . Prospective, randomized comparision of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation. J Pediatrics 1994;124(3):447–454.

    Article  CAS  Google Scholar 

  11. Gupta A, Rastogi S, Sahni R, et al. Inhaled Nitric Oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn–a single center, 5-year experience. J Perinatol 2002;22:435–441.

    Article  Google Scholar 

  12. Finer NN, Sun JW, Rich W, Knodel E, Barrington K . Randomized, prospective study of low-dose versus high-dose Inhaled Nitric Oxide in the neonate with hypoxic respiratory failure. Pediatrics 2001;108(4):949–955.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Phyllis Anderson, RRT, and Kathy Sisco, RN, who helped in data collection and entry.

Author information

Authors and Affiliations

Authors

Additional information

In addition to the authors, the following investigators and institutions participated in this study — John L. Hauver, BA, RRT, Cardinal Glennon Children's Hospital, St. Louis, MO, Al Rastogi, MD, Cook County Hospital, Vivek Ghai, MD, Illinois Masonic Medical, Chicago, IL, Marc G. Weiss, Monika Bhola, MD, Loyola Medical Center, Maywood, IL, Claudia Hart, MD, Magee Women's Hospital, Pittsburgh, PA, Minyuen Enger, MD, Michael Reese Hospital, Chicago, IL, Gary L. Dreyer, MD, St. John's Mercy Medical Center, St. Louis, MO, P. Tom Russell, The Children's Hospital of Illinois, OSF St. Francis Medical Center, Peoria, IL, Shamim Malik, MD, Diane M. Montoto, St. Francis Hospital, EOPC, Tulsa, OK, Ushanalini Vasan, MD, Rush-Presbyterian-St. Luke's Center, Chicago, IL.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sadiq, H., Mantych, G., Benawra, R. et al. Inhaled Nitric Oxide in the Treatment of Moderate Persistent Pulmonary Hypertension of the Newborn: A Randomized Controlled, Multicenter Trial. J Perinatol 23, 98–103 (2003). https://doi.org/10.1038/sj.jp.7210878

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7210878

This article is cited by

Search

Quick links